The Rare Disease Genetic Testing Market is witnessing unprecedented growth, reflecting the rising global focus on precision medicine and advancements in genetic technologies. According to the latest research by SNS Insider, the market was valued at USD 1.05 billion in 2023 and is projected to climb to USD 3.79 billion by 2032. This remarkable growth represents a strong compound annual...